Epilepsy
📧 Sign up to get email alerts when something new happens for Epilepsy.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2009-04-23FDA Approved: ZONEGRAN — Supplemental Application (Advanz Pharma (US) Corp.)
The FDA lists a supplemental application for Zonegran (zonisamide) submitted by Advanz Pharma (US) Corp.
-
FDA approval · 2009-04-21FDA Approved: PRIMIDONE — Supplemental Application (Amneal Pharmaceuticals LLC)
The FDA approved Amneal Pharmaceuticals LLC's supplemental application for Primidone, an anticonvulsant, under the ANDA process.
-
FDA approval · 2009-04-03FDA Approved: LEVETIRACETAM SOLUTION — Original Application (Chartwell RX, LLC)
FDA approved a generic levetiracetam solution (LEVETIRACETAM SOLUTION) under an Original Application by Chartwell RX, LLC. The product provi…
-
FDA approval · 2009-03-31FDA Approved: CARBAMAZEPINE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries' generic carbamazepine via an original ANDA. It is used to treat epilepsy and trigeminal neuralgi…
-
FDA approval · 2009-03-27FDA Approved: TOPIRAMATE — Original Application (Aurobindo Pharma Limited)
FDA approved Aurobindo Pharma Limited's Original Application for Topiramate, granting a generic version of the anticonvulsant Topiramate. Th…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2009-03-27FDA Approved: TOPIRAMATE — Original Application (Cipla USA Inc.)
FDA approved Cipla USA Inc.'s generic Topiramate through an original ANDA.
-
FDA approval · 2009-03-27FDA Approved: TOPIRAMATE — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark's original ANDA for topiramate, enabling a generic version of the anticonvulsant and migraine preventive drug.
-
FDA approval · 2009-03-27FDA Approved: TOPIRAMATE — Original Application (Zydus Lifesciences Limited)
FDA approved a generic Topiramate product (Original Application) from Zydus Lifesciences Limited.
-
CLINICAL_TRIALS trial_result · 2009-03-27Clinical Trial Update: Valproate Sustained Release Minitablets (Orfiril(R) Long) Once Daily in the Evening
This update reports a completed clinical trial evaluating once-daily evening dosing of valproate sustained-release minitablets (Orfiril Long…
-
CLINICAL_TRIALS trial_result · 2009-03-27Clinical Trial Update: Use of the Atkins Diet for Children With Intractable Epilepsy: A Comparison of Daily Carbohydrate Limits [Phase 1]
A Phase 1 trial exploring how different daily carbohydrate limits in the Atkins diet affect seizure control in children with intractable epi…
-
FDA approval · 2009-03-27FDA Approved: TOPIRAMATE — Original Application (Cipla USA Inc.)
FDA approval of a generic Topiramate product from Cipla USA Inc. (Original Application).
-
FDA approval · 2009-03-27FDA Approved: TOPIRAMATE — Original Application (Unichem Pharmaceuticals (USA), Inc.)
The FDA approved Unichem Pharmaceuticals (USA), Inc.'s original application for a generic Topiramate product, expanding access to this anti-…
-
FDA approval · 2009-03-27FDA Approved: TOPIRAMATE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical's Original Application for Topiramate, enabling the generic Topiramate to be marketed.
-
FDA label_change · 2009-03-25FDA Approved: LAMOTRIGINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for lamotrigine from Sun Pharmaceutical Industries, Inc.
-
CLINICAL_TRIALS research · 2009-03-19Clinical Trial Update: Ketogenic Diet vs.Antiepileptic Drug Treatment in Drug Resistant Epilepsy [Phase 4]
A Phase 4 clinical trial update comparing ketogenic diet with standard antiepileptic drug therapy in drug-resistant epilepsy, sponsored by O…
-
FDA approval · 2009-02-27FDA Approved: DIVALPROEX SODIUM — Original Application (BluePoint Laboratories)
FDA approved the original application for divalproex sodium (generic) by BluePoint Laboratories.
-
CLINICAL_TRIALS research · 2009-02-25Clinical Trial Update: Genetic Basis of Idiopathic Focal Epilepsies With Cognitif Deficits [NA]
A clinical trials update from University Hospital, Strasbourg investigates the genetic basis of idiopathic focal epilepsies with cognitive d…
-
FDA approval · 2009-02-19FDA Approved: LAMOTRIGINE — Original Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved an original application for a generic lamotrigine product manufactured by Glenmark Pharmaceuticals Inc., expanding generic …
-
FDA approval · 2009-02-12FDA Approved: KEPPRA XR — Supplemental Application (UCB, Inc.)
The FDA approved a supplemental application for KEPPRA XR (levetiracetam) from UCB, Inc.
-
FDA approval · 2009-02-10FDA Approved: LEVETIRACETAM — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries' original application for levetiracetam, enabling a generic version of the antiseizure medication…
-
CLINICAL_TRIALS withdrawal · 2009-02-10Clinical Trial Update: fMRI Investigation of Depression in Patients With Epilepsy
The clinical trial investigating fMRI assessment of depression in patients with epilepsy has been withdrawn.
-
FDA approval · 2009-01-29FDA Approved: MYSOLINE — Supplemental Application (Bausch Health US, LLC)
FDA approved a supplemental application for MYSOLINE (primidone) submitted by Bausch Health US, LLC.
-
FDA approval · 2009-01-27FDA Approved: LAMOTRIGINE — Original Application (Advagen Pharma Limited)
FDA approved Advagen Pharma Limited's Original Application for lamotrigine, enabling a generic lamotrigine product.
-
FDA approval · 2009-01-27FDA Approved: LAMOTRIGINE KIT — Original Application (OWP Pharmaceuticals, Inc.)
FDA approves Lamotrigine Kit under an original ANDA application by OWP Pharmaceuticals, Inc. for generic lamotrigine products.
-
FDA approval · 2009-01-27FDA Approved: LAMOTRIGINE — Original Application (Jubilant Cadista Pharmacuticals Inc.)
FDA approved Jubilant Cadista Pharmaceuticals Inc.'s original ANDA for lamotrigine, establishing a generic lamotrigine product.